China Pharma
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $756,217,000 | $1,025 | $1,136 | $1,133 |
Gross Profit | -59,654,000 | -87 | -136 | -55 |
EBITDA | 378,773,350 | -180 | -746 | |
EBIT | -627,436,000 | -501 | -1,194 | |
Net Income | -651,482,000 | -528 | -785 | -1,224 |
Net Change In Cash | 756,217,000 | 1,025 | 1,136 | 1,133 |
Free Cash Flow | -237 | 281 | -138 | -34 |
Cash | 267 | 625 | 412 | 626 |
Basic Shares | 3,874 | 3,262 | 4,259 | 4,758 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $4,528 | $7,011 | $8,104 | $9,641 |
Gross Profit | -1,985 | -281 | -493 | 349 |
EBITDA | -1,964 | 8 | -837 | 230 |
EBIT | -4,582 | -2,745 | -3,538 | -2,857 |
Net Income | -4,736 | -3,078 | -3,972 | -3,399 |
Net Change In Cash | 4,528 | 7,011 | 8,104 | 9,641 |
Free Cash Flow | -758 | -711 | -811 | -687 |
Cash | 626 | 1,423 | 2,029 | 4,859 |
Basic Shares | 17,463 | 10,599 | 5,256 | 4,612 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.17 |
2025-06-30 | -$0.16 |
2025-03-31 | -$0.24 |
2024-12-31 | -$0.53 |
